SPACs
The latest SPACs coverage from the Boardroom Alpha desk. Back to all research.
SPACs
Page 32
Cannabis SaaS Play springbig Gets Valuation Haircut
Amended deal terms for TCAC/springbig. 2 SPAC deals today. And the rest of the day’s news in SPACs.
SPAC Market Review – April 2022
The market is a mess right now. A hawkish Fed and even more cautious SEC are slowing deals….but may raise the bar for more quality SPACs down the line.
More COVFEFE. DWAC Jumps as Trump Posts on Truth Social
DWAC jumps as Trump returns to Truth Social. NuScale Power (SMR) begins trading next week. Zanite (ZNTE) / Eve makes noise ahead of next week’s merger vote. And the rest of the…
SoundHound Debuts Today in the Red
Speech recognition specialist Soundhound (SOUN) debuts today. More SPAC liquidations ahead? And the rest of the day’s news in SPACs.
The Green Energy Movement will be Digitized, says Voltus CEO Gregg Dixon
Voltus is gearing up for a $1.3B SPAC IPO in the coming months. We chat with CEO Gregg Dixon, who shares how the company is leading the charge to decentralize, decarbonize and…
DA for ISLE / Cytovia Therapeutics
DA for ISLE / Cytovia Therapeutics. Soundhound (SOUN) debuts tomorrow. And the rest of the day’s news in SPACs.
SPAC IPO for Aimfinity
An IPO and another metaverse play. Elon buying TWTR is a good time for a DWAC and CFVI status check. And the rest of the day’s news in SPACs.
Two SPAC Deals to Start the Week
Monday’s buzzing with two med-related SPAC deals. Convert and PIPE action. And the rest of the day’s news in SPACs.
DA for LMAO and SeaStar Medical
Ending the week with a deal announcement for LMAO and SeaStar Medical. And the rest of the day’s news in SPACs.
SPAC Redemptions Continue to Trend Lower
An updated look at redemption trends for the month of April. Deadline extensions for FOXW and GRCY. And the rest of the day’s news in SPACs.
Yotta Acquisition Prices $100M IPO
SPAC IPO for Yotta, convert for SWAG and the rest of the day’s news in SPACs.
SPAC Deal for Bull Horn and Cancer Cell Therapy Specialist Coeptis Therapeutics
SPAC Deal for BHSE and cancer cell therapy biopharma Coeptis. Merger votes for Tempo Automation and Telesign. And the rest of the day’s news in SPACs.
Origin Materials on Paving the Way Toward a Carbon Negative Future
John Bissell and Rich Riley, Co-CEOs of Origin Materials (ORGN) tell us how bioplastics are ready and able to reduce our reliance on fossil fuels.
Third Time’s a Charm for ESSC
ESSC announces DA with ICONIQ, its third after terminating with both JDS and Ufin Holdings. DUNE heads to court with its merger target. And the rest of the day’s news in SPACs.
SeatGeek-Redball IPO in the Spotlight
RBAC amended its S-4 for its merger with ticketing tech provider SeatGeek. Redemption update at GLSPT. And the rest of the day’s news in SPACs.
ALAC Breaks up with SolarMax
Adding to the wave of deal terminations, Alberton Acquisition Corp. (ALAC) intends to terminate its merger with SolarMax. And the rest of the day’s news in SPACs.
Danimer Scientific’s CEO on How Bioplastics Can Help Save the World
Boardroom Alpha talks to Steve Croskrey, CEO of Danimer Scientific (DNMR), on why bioplastics technology is ready for takeoff and how the company is moving the world toward a…
Spotify Rival Deezer to Go Public via SPAC
Spotify rival Deezer is said to be in talks with I2PO, a SPAC backed by France’s Pinault family, controlling shareholder of Gucci-owner Kering. A $100M IPO for Southeast…
SPAC Deal for 8i and EUDA Health
SPAC deal for 8i Acquisition 2 Corp. (LAX) and EUDA Health. A look at upcoming merger and extension votes. And the rest of the day’s news in SPACs.
ARTA / Prenetics Sets Merger Vote
Vote date set for Hong-Kong based COVID-19 lab provider Prenetics. A look at upcoming merger and extension votes. And the rest of the day’s news in SPACs. And the rest of the…
FOXO Technologies CEO Jon Sabes Is About to Disrupt the Insurance Industry
Boardroom Alpha talks to Jon Sabes, CEO of FOXO Technologies, which announced a SPAC merger with sponsor Delwinds Insurance Acquisition Corp. (DWIN). Sabes explains how epigenetic…
NuScale Set for Merger Approval
We wrap a busy week in SPACs: deSPACs, DAs…and even some old fashioned rumor and speculation is back.
In a Nod to the SEC, Citi Redlights SPACs
WIth the SEC’s new rules looming large, Citi says no more SPAC IPO underwriting for now. A SPAC IPO is offset by two withdrawals. And the rest of the day’s news in SPACs.
Citi Redlights SPACs as Potential Liability Looms Large
Citigroup (C) pauses underwriting new SPAC IPOs amidst the potential for incremental legal risks. Regulatory scrutiny and monetary tightening are likely to mean more pain for the…